Principal Scientist / Associate Principal Scientist
• Extensively contributed to the ongoing development of a drug candidate to treat type-2 diabetes.• Planned and coordinated animal efficacy studies with an external CRO.• Designed chemistry experiments and solved problems for chemists working at a CRO firm that Merck was collaborating with.• Co-invented a best-in-class drug candidate to treat patients infected with hepatitis C virus. • Made key innovation to improve the pharmacokinetic profile that resulted in the discovery of a best-in-class HCV clinical candidate.